Table 4 Results, discussion and conclusions concerning efficacy
From: Questions asked and answered in pilot and feasibility randomized controlled trials
|
Drug (n = 28) |
Non-drug (n = 22) | ||
|---|---|---|---|
| ABSTRACT | |||
| Take home message | no mention of efficacy | 4 (14%) | 4 (18%) |
| not shown to have benefit/no benefit | 4 (14%) | 1 (5%) | |
| intervention shows promise | 8 (29%) | 5 (23%) | |
| intervention beneficial | 12 (43%) | 12 (55%) | |
| Mentioned that further/larger trials needed | 13 (46%) | 11 (50%) | |
| RESULTS | |||
| Statistically significant | none | 12 (43%) | 9 (43%) |
| results relating to efficacy | within groups only | 5 (18%) | 4 (19%) |
| between groups | 11 (39%) | 8 (38%)1 | |
| DISCUSSION | |||
| Extent of discussion about | minimal | 1 (4%) | 3 (14%) |
| efficacy | substantial | 11 (39%) | 9 (41%) |
| major focus of section | 16 (57%) | 10 (46%) | |
| Mentioned that the sample size was too small | 24 (86%) | 19 (88%) | |
